JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beavis, R. E.
Right arrow Articles by Worner, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beavis, R. E.
Right arrow Articles by Worner, M. J.

The Journal of Thoracic and Cardiovascular Surgery, Vol 95, 1059-1066, Copyright © 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

An experimental in vivo study of the canine internal mammary artery and its response to vasoactive drugs

RE Beavis, CJ Mullany, KD Cronin, DA Scott, BC Treagus, Y Zhikun and MJ Worner
University of Melbourne, Department of Surgery, Australia.

The internal mammary artery is clearly the preferred conduit for most patients undergoing coronary artery bypass grafting. However, the hemodynamic responses of this graft to vasoactive agents immediately after bypass have not been documented. We have therefore studied blood flow in the canine internal mammary artery after anastomosis to the left anterior descending artery, and its response to epinephrine, metaraminol, isoproterenol, and calcium chloride. Blood flow in the internal mammary artery clearly paralleled changes in systolic blood pressure with perfusion pressure being of prime importance in maintaining flow in the internal mammary artery. No deleterious effect of systemic vasoconstricting agents was demonstrated. We suggest that the administration of these drugs is safe in patients with internal mammary artery grafts.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
F. L. Rosenfeldt, G.-W. He, B. F. Buxton, and J. A. Angus
Pharmacology of coronary artery bypass grafts
Ann. Thorac. Surg., March 1, 1999; 67(3): 878 - 888.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
P. Kam, L. Hines, and E. O'Connor
Effects of cardiopulmonary bypass on systemic vascular resistance
Perfusion, January 1, 1996; 11(4): 346 - 350.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 by The American Association for Thoracic Surgery.